Cleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut. The findings pave the way for potential new treatments for a variety of inflammatory and ...

Flagship Pioneering introduced the latest company, Mirai Bio, during the BioProcess International Conference in Boston.

MED6-189 targets and disrupts the parasite’s apicoplast and also vesicular trafficking pathways, a dual mode of action that ...

As Congress wrangles over a budget for the 2025 federal fiscal year, which begins October 1, the NIH will be paying especially close attention. Last year, the NIH saw its first year-over-year funding ...

Researchers suggest the DeepRVAT model is the first to use artificial intelligence (AI) in genomic association studies to decipher rare genetic variants.

The developers of the model claim it is the first developed specifically to identify drugs for rare diseases and conditions ...

Sixteen patients dosed with Pfizer’s sickle cell disease drug Oxbryta® (voxelotor) in a pair of clinical trials have died, ...

NIM Agent Blueprint based on cloud-native "microservices" aim to accelerate virtual screening of small molecules using ...

While the cell and gene therapy industry has recognized its potential, few companies to date have embraced artificial ...

Showing the power of modeling in gathering valuable information could encourage more people to use these tools for their own ...

A number of cell culture experts maintain that innovation in this sector has been limited, leading to challenges in industrial scaling.

Whether lessons from the COVID-19 pandemic will be implemented in time for the next pandemic remains to be seen.